Apellis Pharmaceuticals, Inc. APLS
41.03 USD 0.00 (+0.00%)
At closeMay 15, 2026, 4:00 PM EDT
41.06 +0.03 +0.07%
After hours · May 15, 4:00 PM ET
41.03 Day range 41.05
52-week range unavailable
- YTD
- +63.34%
- 1 year
- +150.79%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 1.00B | 781.37M | 396.59M | 75.42M | 66.56M | |
| 901.55M | 663.64M | 338.08M | 69.79M | 66.36M | |
| 55.43M | -164.98M | -517.12M | -594.61M | -536.28M | |
| 22.39M | -197.88M | -528.63M | -652.17M | -746.35M | |
| 0.20 | -1.60 | -4.45 | -6.15 | -8.84 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 467.76M | 412.61M | 352.30M | 553.07M | 641.75M | |
| 1.08B | 885.05M | 788.73M | 760.22M | 881.76M | |
| 705.11M | 656.51M | 594.21M | 590.35M | 683.10M | |
| 474.36M | 469.78M | 110.93M | 112.71M | 210.22M | |
| 370.15M | 228.54M | 194.52M | 169.87M | 198.66M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 45.33M | -87.87M | -594.74M | -513.75M | -563.13M | |
| -313.00K | -403.00K | -674.00K | 59.89M | 247.62M | |
| 8.88M | 149.24M | 394.50M | 365.66M | 392.24M | |
| -313.00K | -403.00K | -674.00K | -1.52M | -1.10M | |
| 55.15M | 60.31M | -200.78M | -88.68M | 74.71M |